arrow
返回
E

Evan Y. Yu

university of washington

60H指数
560论文数
2.3W被引数
收录论文 111
发表时间
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study膀胱癌亚型组织学患者中经尿道膀胱肿瘤切除术与根治性膀胱切除术病理结果的一致性:一项回顾性队列研究
err2025-11-01
err0
PREAI
errBakaloudi, Dimitra Rafailia; Koehne, Elizabeth L.; Voutsinas, Jenna M.; Diamantopoulos, Leonidas N.; Makrakis, Dimitrios; Grivas, Petros; True, Lawrence D.; Tretiakova, Maria S.; Vakar-Lopez, Funda; Psutka, Sarah P.; Holt, Sarah K.; Gore, John L.; Lin, Daniel W.; Schade, George R.; Nyame, Yaw A.; Hsieh, Andrew C.; Yezefski, Todd; Hawley, Jessica E.; Schweizer, Michael T.; Cheng, Heather H.; Yu, Evan Y.; Montgomery, R. Bruce; Wu, Qian; Wright, Jonathan L.
err分享
err收藏
DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysisDARolutamide观察性(DAROL)研究:非转移性去势抵抗性前列腺癌患者的预先设定第三次中期分析
err2025-11-01
err0
errOAAI
errEvan Y. Yu; Hiroyoshi Suzuki; Christopher M. Pieczonka; Geoffrey Gotto; Alberto Briganti; Murilo Luz; Declan Murphy; Ryan Malone; Joelle Hamilton; Jonathan E. Chan; Paul Sieber; Robert W. Given; Eva Hellmis; Thomas Kretz; Philipp Spiegelhalder; Antonio Gómez-Caamaño; Yaovi Messan Amela; Xavier Artignan; Hiroji Uemura; Naoki Fujita; Patrick Adorjan; Mercedeh Ghadessi; Frank Verholen; Andrew J. Armstrong
err分享
err收藏
Validating Calibration of an Artificial Intelligence Assessment of Endoscopic Severity in Ulcerative Colitis验证人工智能评估溃疡性结肠炎内镜严重程度的校准
err2025-10-01
err0
PREAI
errBattioui, Chakib; Brodskiy, Pavel; Gottlieb, Klaus; Haft-Javaherian, Mohammad; Eastman, William J.; Lehrer, Julian; Yu, Evan; Onken, Derek; Thomason, Darren; Reinisch, Walter; Colucci, Daniel; Baxi, Shrujal
err分享
err收藏
Exploratory subgroup analyses of EV-302: a phase III global study to evaluate enfortumab vedotin in combination with pembrolizumab versus chemotherapy in previously untreated locally advanced or metastatic urothelial carcinomaEV-302研究的探索性亚组分析:一项评估恩诺单抗(enfortumab vedotin)联合帕博利珠单抗(pembrolizumab)与化疗对比治疗既往未治疗的局部晚期或转移性尿路上皮癌的III期全球研究
err2025-08-11
err0
errOAAI
errM.S. van der Heijden; T. Powles; S. Gupta; Y. Loriot; M.D. Galsky; B.P. Valderrama; S.S. Sridhar; E.Y. Yu; G. Iyer; E. Kikuchi; D. Castellano; J. Hoffman-Censits; A. Drakaki; N. Mar; J.P. Maroto Rey; C. Vulsteke; W. Arafat; I. Duran; N.A. Dawson; U. Swami; S. Gorla; B.H. Moreno; X. Yu; Y.-T. Lu; J. Bedke
err分享
err收藏
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate CancerKEYLYNK-010研究中患者报告结局:帕博利珠单抗联合奥拉帕利与阿比特龙或恩扎卢胺治疗生物标志物未筛选、既往接受过治疗的转移性去势抵抗性前列腺癌患者
err2025-07-19
err0
errOAAI
errNiven Mehra; Emmanuel S. Antonarakis; Se Hoon Park; Jeffrey C. Goh; Ray McDermott; Nuria Sala Gonzalez; Peter C. Fong; Richard Greil; Maria De Santis; Patricio Eduardo Yanez; Yi-Hsiu Huang; Stephen D. Begbie; Felipe Rey; Gero Kramer; Hiroyoshi Suzuki; Todd L. Saretsky; Sameer R. Ghate; Yi Cui; Christian Hosius; Evan Y. Yu
err分享
err收藏
Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes
err2025-02-07
err0
PREAI
errRuben Raychaudhuri; Abuzar Moradi Tuchayi; Soon Khai Low; Ali T. Arafa; Laura S. Graham; Roman Gulati; Colin C. Pritchard; Robert B. Montgomery; Michael C. Haffner; Peter S. Nelson; Evan Y. Yu; Jessica E. Hawley; Heather H. Cheng; George Mo; Delphine L. Chen; Emmanuel S. Antonarakis; Deepak Kilari; Thomas A. Hope; Amir Iravani; Michael T. Schweizer
err分享
err收藏
Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial阿特珠单抗单药治疗转移性尿路上皮癌: imvior210 II期临床试验的最终分析
err2024-12-01
err0
PREAI
errRosenberg, J. E.; Galsky, M. D.; Powles, T.; Petrylak, D. P.; Bellmunt, J.; Loriot, Y.; Necchi, A.; Hoffman-Censits, J.; Perez-Gracia, J. L.; van der Heijden, M. S.; Dreicer, R.; Duran, I.; Castellano, D.; Drakaki, A.; Retz, M.; Sridhar, S. S.; Grivas, P.; Yu, E. Y.; O'Donnell, H.; Burris, H. A.; Mariathasan, S.; Shi, Y.; Goluboff, E.; Bajorin, D.
err分享
err收藏
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177Lu-PSMA-617: Importance of 18F-FDG-Avid Discordant Findings基于PET的TheraP资格及VISION试验合格患者中接受177Lu-PSMA-617治疗的转移性去势抵抗性前列腺癌患者的结局:18F-FDG显像不一致结果的重要性
err2024-11-14
err1
PREAI
errDemirci, Ridvan Arda; Ghodsi, Alireza; Gulati, Roman; Behnia, Sanaz; Nelson, Peter S.; Cheng, Heather H.; Yezefski, Todd A.; Haffner, Michael C.; Hawley, Jessica E.; Montgomery, Robert B.; Yu, Evan Y.; Schweizer, Michael T.; Chen, Delphine L.; Iravani, Amir
err分享
err收藏
SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving 177Lu-PSMA-617
err2024-11-07
err0
PREAI
errDemirci, Ridvan Arda; Gulati, Roman; Hawley, Jessica E.; Yezefski, Todd; Haffner, Michael C.; Cheng, Heather H.; Montgomery, Robert B.; Schweizer, Michael T.; Yu, Evan Y.; Nelson, Peter S.; Chen, Delphine L.; Iravani, Amir
err分享
err收藏
Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study曲妥珠单抗Deruxtecan联合Nivolumab HER2-Expressing转移性乳腺癌或尿路上皮癌: Ib期DS8201-A-U105研究分析
err2024-10-15
err0
errOAAI
errHamilton, Erika; Galsky, Matthew D.; Ochsenreither, Sebastian; Del Conte, Gianluca; Martin, Miguel; De Miguel, Maria Jose; Yu, Evan Y.; Williams, Anja; Gion, Maria; Tan, Antoinette R.; Agrawal, Laila; Rutten, Annemie; Machiels, Jean-Pascal; Cresta, Sara; Debruyne, Philip R.; Hennequin, Audrey; Moreno, Victor; Minchom, Anna; Valdes-Albini, Frances; Petrylak, Daniel; Li, Li; Tsuchihashi, Zenta; Suto, Fumitaka; Cheng, Fu-Chih; Kandil, Maha; Barrios, Daniel; Hurvitz, Sara
err分享
err收藏
Tucatinib and Trastuzumab for Patients With Previously Treated, HER2-Altered Solid Tumors (SGNTUC-019): A Phase 2 Basket Study
err2024-10-01
err0
PREAI
errNakamura, Y.; Bekaii-Saab, T.; Hamilton, E.; Hayashi, H.; Mizuno, N.; Monk, B. J.; Nguyen, D.; Okines, A.; O'Malley, D. M.; Pohlmann, P. R.; Pothuri, B.; Reck, M.; Sudo, K.; Sunakawa, Y.; Takahashi, S.; Yu, E. Y.; Drees, A.; Tan, S.; Stinchcombe, T. E.
err分享
err收藏
Head-to-Head Evaluation of Two Machine Learning Algorithms for Predicting Endoscopic Mayo Score in Ulcerative Colitis
err2024-10-01
err0
PREAI
errBattioui, Chakib; Brodskiy, Pavel; Gottlieb, Klaus; Haft-Javaherian, Mohammad; Baxi, Shrujal; Yu, Evan
err分享
err收藏
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 StudyPembrolizumab和恩扎鲁他胺治疗经醋酸阿比曲酮预处理的转移性去势抵抗性前列腺癌患者: 1b/2期KEYNOTE-365研究的队列C
err2024-06-01
err0
errOAAI
errYu, Evan Y.; Berry, William R.; Gurney, Howard; Retz, Margitta; Conter, Henry J.; Laguerre, Brigitte; Fong, Peter C. C.; Ferrario, Cristiano; Todenhofer, Tilman; Gravis, Gwenaelle; Piulats, Josep M.; Emmenegger, Urban; Shore, Neal D.; Romano, Emanuela; Mourey, Loic; Li, Xin Tong; Poehlein, Christian H.; Schloss, Charles; Appleman, Leonard J.; Bono, Johann S. de
err分享
err收藏
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial
err2024-06-01
err0
errOAAI
errPowles, Thomas; Chang, Yen-Hwa; Yamamoto, Yoshiaki; Munoz, Jose; Reyes-Cosmelli, Felipe; Peer, Avivit; Cohen, Graham; Yu, Evan Y.; Lorch, Anja; Bavle, Abhishek; Moreno, Blanca Homet; Markensohn, Julia; Edmondson, Mackenzie; Chen, Cai; Cristescu, Razvan; Pena, Carol; Lunceford, Jared; Gunduz, Seyda
err分享
err收藏
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
err2024-05-17
err3
errOAAI
errAjkunic, Azra; Sayar, Erolcan; Roudier, Martine P.; Patel, Radhika A.; Coleman, Ilsa M.; De Sarkar, Navonil; Hanratty, Brian; Adil, Mohamed; Zhao, Jimmy; Zaidi, Samir; True, Lawrence D.; Sperger, Jamie M.; Cheng, Heather H.; Yu, Evan Y.; Montgomery, Robert B.; Hawley, Jessica E.; Ha, Gavin; Persse, Thomas; Galipeau, Patricia; Lee, John K.; Harmon, Stephanie A.; Corey, Eva; Lang, Joshua M.; Sawyers, Charles L.; Morrissey, Colm; Schweizer, Michael T.; Gulati, Roman; Nelson, Peter S.; Haffner, Michael C.
err分享
err收藏
THIRD INTERIM ANALYSIS (IA3) OF THE DAROLUTAMIDE OBSERVATIONAL (DAROL) STUDY IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC)
err2024-05-01
err0
PREAI
errGotto, Geoffrey; Suzuki, Hiroyoshi; Luz, Murilo; Briganti, Alberto; Yu, Evan Y.; Pieczonka, Christopher; Murphy, Declan; Malone, Ryan; Hamilton, Joelle; Chan, Jonathan E.; Sieber, Paul; Given, Robert W.; Adorjan, Patrick; Ghadessi, Mercedeh; Verholen, Frank; Armstrong, Andrew J.
err分享
err收藏
Interim results of the ongoing phase 1-2 clinical trial of KVA12123, an engineered IgG1 targeting VISTA, as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors
err2024-04-05
err0
PREAI
errYu, Evan Y.; Henry, Jason; Patel, Manish R.; Swiecicki, Paul; Micaily, Ida; Garmezy, Benjamin; Banda, Kalyan; Hayreh, Vinny; Lustig, Kurt; Ovechkina, Yulia; Iadonato, Shawn P.; Guillaudeux, Thierry; Rosen, Lee
err分享
err收藏
A randomized phase II study of atezolizumab (atezo) plus recombinant human IL-7 (CYT107) vs. atezo alone in patients with locally advanced or metastatic urothelial carcinoma (mUC)
err2023-10-01
err0
errOAAI
errPachynski, R.; Chatta, G.; Jain, R. K.; Moon, H.; Sweis, R.; Delacroix, S.; Fang, T.; Fling, S. P.; Lacroix, A.; Kaiser, J.; Sharon, E.; Yu, E.
err分享
err收藏